https://www.selleckchem.com/pr....oducts/gsk1120212-jt
reducing cholesterol levels and ASCVD events. With the new FDA approval, bempedoic acid may offer an effective therapy for reducing low-density lipoprotein cholesterol in patients at high risk for cardiovascular events due to established ASCVD or heterozygous familial hypercholesterolemia. Age- and intent-related differences in the burden and costs of firearm injury treated in emergency departments are not well-documented. We performed a serial cross-sectional study of the Healthcare Cost and Utilization Program Nationwide
Like
Comment
Share
